Before taking Revolade(Eltrombopag)

Key warnings involve liver toxicity, thrombotic complications, and cataract risks, necessitating regular monitoring.

Precautions

PROMACTA carries a boxed warning for hepatotoxicity and hepatic decompensation in hepatitis C patients. It may increase the risk of thrombosis, especially in those with chronic liver disease. Cataracts have been observed in patients, requiring baseline and periodic eye exams. Laboratory test interference can occur due to the drug's color, affecting bilirubin and creatinine readings. Dose adjustments are needed for hepatic impairment or specific ethnicities to minimize risks.